LU47099A1 - - Google Patents

Info

Publication number
LU47099A1
LU47099A1 LU47099A LU47099A LU47099A1 LU 47099 A1 LU47099 A1 LU 47099A1 LU 47099 A LU47099 A LU 47099A LU 47099 A LU47099 A LU 47099A LU 47099 A1 LU47099 A1 LU 47099A1
Authority
LU
Luxembourg
Application number
LU47099A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DE19651518874 priority Critical patent/DE1518874C3/de
Priority to DE19651518877 priority patent/DE1518877C3/de
Priority to DE19651518879 priority patent/DE1518879C3/de
Priority to DE19651518878 priority patent/DE1518878A1/de
Publication of LU47099A1 publication Critical patent/LU47099A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/59—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU47099A 1963-10-19 1964-10-07 LU47099A1 (xx)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19651518874 DE1518874C3 (de) 1964-10-07 1965-10-05 Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE19651518877 DE1518877C3 (de) 1964-10-07 1965-10-07 Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE19651518879 DE1518879C3 (de) 1964-10-07 1965-10-07 Benzolsulfonylharnstoffe, Verfahren zu Ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE19651518878 DE1518878A1 (de) 1964-10-07 1965-10-07 Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEF41042A DE1185180B (de) 1963-10-19 1963-10-19 Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DEF0042062 1964-02-20
DEF0042933 1964-05-21
DEF0043268 1964-06-26

Publications (1)

Publication Number Publication Date
LU47099A1 true LU47099A1 (xx) 1966-04-07

Family

ID=27436911

Family Applications (1)

Application Number Title Priority Date Filing Date
LU47099A LU47099A1 (xx) 1963-10-19 1964-10-07

Country Status (21)

Country Link
US (2) US3426067A (xx)
AT (5) AT262309B (xx)
BE (1) BE654561A (xx)
CH (1) CH529115A (xx)
CY (1) CY436A (xx)
DE (1) DE1185180B (xx)
DK (7) DK119052B (xx)
ES (1) ES312472A1 (xx)
FI (1) FI44597B (xx)
FR (2) FR1473834A (xx)
GB (1) GB1080705A (xx)
IL (1) IL22259A (xx)
IS (1) IS765B6 (xx)
IT (1) IT1061504B (xx)
LU (1) LU47099A1 (xx)
MC (1) MC488A1 (xx)
MY (1) MY6800113A (xx)
NL (1) NL6412137A (xx)
NO (1) NO118548B (xx)
OA (1) OA01367A (xx)
SE (8) SE311151B (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (de) * 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1493672C3 (de) * 1964-08-01 1974-05-02 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1443905C3 (de) * 1964-10-30 1979-03-15 Hoechst Ag, 6000 Frankfurt benzolsulfonyl] -N'-cyclohexylharnstoff, Verfahren zu seiner Herstellung und seine Verwendung
DE1518816C3 (de) * 1965-03-24 1975-05-22 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4066639A (en) * 1965-05-06 1978-01-03 Hoechst Aktiengesellschaft Benzene-sulfonyl semicarbazides and process for preparing them
US3454635A (en) * 1965-07-27 1969-07-08 Hoechst Ag Benzenesulfonyl-ureas and process for their manufacture
DE1518895C3 (de) * 1965-12-02 1978-12-07 Hoechst Ag, 6000 Frankfurt Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
DE1244174C2 (de) * 1965-09-10 1968-01-18 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
US3932503A (en) * 1966-05-28 1976-01-13 Hoechst Aktiengesellschaft Benzenesulfonyl ureas
US3932658A (en) * 1969-02-25 1976-01-13 Hoechst Aktiengesellschaft Composition and method for lower blood sugar containing N-[4-(β-<2-methoxy-5-chloro-benzamido>-ethyl)-benzenesulfonyl]-N'-cyclopentyl-urea
NL138933B (nl) * 1969-03-26 1973-05-15 Erba Carlo Spa Werkwijze voor het bereiden van benzeensulfonylureumderivaten met bloedsuikerspiegelverlagende werking.
BE754454A (fr) * 1969-08-06 1971-02-05 Bayer Ag Nouveaux composes hypoglycemiques du type d'arylsulfonylurees et d'arylsulfonylsemicarbazides contenant des groupes carbonamide
ES384463A1 (es) * 1970-09-23 1973-10-01 Uriach & Cia Sa J Procedimiento para la obtencion de n-4 - (beta-o-anisamido etil) - bencenosulfonil - n'ciclopentilcarbamida.
US3957866A (en) * 1970-09-23 1976-05-18 J. Uriach & Cia S.A. Cyclopentyl carbamide derivative and process for its production
US4072758A (en) * 1970-09-23 1978-02-07 J. Uriach Y Cia, S.A. Compositions and methods for effecting glucoreduction
BE791638A (fr) * 1971-11-20 1973-05-21 Hoechst Ag Sulfonyl-urees, leur procede de preparation et leurs applications
DE2230543A1 (de) * 1972-06-22 1974-01-17 Hoechst Ag Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung
US4067998A (en) * 1974-02-11 1978-01-10 The Dow Chemical Company 2-((3,5-Di-tert-butylphenyl)thio) alkanoic acids and derivatives
DE2413514C3 (de) * 1974-03-21 1982-03-04 Hoechst Ag, 6000 Frankfurt N-Acylaminoathylbenzolsulfonyl-N'-methylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
AU528362B2 (en) * 1978-06-22 1983-04-28 Societe D:Etudes De Produits Chimiques Phenoxy isobutyramides
DE3211934A1 (de) * 1982-03-31 1983-10-13 Hoechst Ag, 6230 Frankfurt Salicylsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
DK0612724T3 (da) * 1993-02-23 1997-06-16 Hoechst Ag Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og deres anvendelse som farmaceutika
HU226462B1 (en) * 1995-02-17 2008-12-29 Hoechst Ag Substituted benzol-sulfonyl-ureas and -thioureas, process for producing them, pharmaceutical compositions containing them, and their use
ID28854A (id) * 1998-09-10 2001-07-05 Aventis Pharma Gmbh Penggunaan benzenasulfonil(tio) urea untuk pengobatan dan pencegahan disfungsi sitem saraf otonom dan penggunaan benzenasulfonil(tio) urea secara berkombinasi dengan penghalang beta-reseptor
DE19923086A1 (de) 1999-05-20 2000-11-23 Aventis Pharma Gmbh Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054482A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
AU2003224917A1 (en) * 2002-04-11 2003-10-27 Carbomer Diabetes imaging probes
US20060201981A1 (en) * 2003-06-30 2006-09-14 Meyer Dean E Clip support member for golf bag
EP1899294B1 (en) * 2005-06-13 2015-03-18 Merck Sharp & Dohme Limited Therapeutic agents
WO2010048287A2 (en) 2008-10-22 2010-04-29 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Radioprotective agents
WO2012079164A1 (en) * 2010-12-16 2012-06-21 The Governing Council Of The University Of Toronto Activators of cylindrical proteases
CA3059458A1 (en) 2017-05-24 2018-11-29 The University Of Queensland Novel compounds and uses
CN112979571B (zh) * 2021-02-24 2023-01-31 中国药科大学 一类akr1c3选择性抑制剂及其制备方法与用途
EP4341246A1 (en) * 2021-05-17 2024-03-27 The United States of America, as represented by The Secretary, Department of Health and Human Services A facile and odor-free approach to convert sulfonyl urea derivatives to chalcogenide sulfonyl urea derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL218580A (xx) * 1960-04-28
DE1185180B (de) * 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen

Also Published As

Publication number Publication date
AT278027B (de) 1970-01-26
DK120742B (da) 1971-07-12
IT1061504B (it) 1983-04-11
MC488A1 (fr) 1965-06-04
DE1443890A1 (de) 1969-02-20
SE334621B (xx) 1971-05-03
DK120588B (da) 1971-06-21
DK120534B (da) 1971-06-14
MY6800113A (en) 1968-12-31
IS765B6 (is) 1970-12-01
FR1473834A (fr) 1967-03-24
SE334604B (xx) 1971-05-03
ES312472A1 (es) 1967-04-01
DK119105B (da) 1970-11-16
DE1443878B2 (de) 1973-02-01
IS1424A7 (is) 1964-10-16
DK119455B (da) 1971-01-11
US3507961A (en) 1970-04-21
FR4316M (xx) 1966-08-01
AT261627B (de) 1968-05-10
IL22259A (en) 1969-05-28
DK119052B (da) 1970-11-09
DE1185180B (de) 1965-01-14
BE654561A (xx) 1965-04-20
CH529115A (de) 1972-10-15
NL6412137A (xx) 1965-04-20
AT262308B (de) 1968-06-10
SE334607B (xx) 1971-05-03
AT262309B (de) 1968-06-10
GB1080705A (en) 1967-08-23
DE1443890B2 (de) 1973-02-01
SE334603B (xx) 1971-05-03
DE1443878A1 (de) 1968-12-12
SE334605B (xx) 1971-05-03
CY436A (en) 1968-03-22
NO118548B (xx) 1970-01-12
DE1443894A1 (de) 1969-04-24
SE334606B (xx) 1971-05-03
SE311151B (xx) 1969-06-02
AT267541B (de) 1969-01-10
FI44597B (xx) 1971-08-31
US3426067A (en) 1969-02-04
SE334608B (xx) 1971-05-03
DK120741B (da) 1971-07-12
OA01367A (fr) 1969-07-04

Similar Documents

Publication Publication Date Title
FI44597B (xx)
BE623315A (xx)
BE635736A (xx)
BE623162A (xx)
BE462764A (xx)
BE465565A (xx)
BE639885A (xx)
BE635714A (xx)
BE627172A (xx)
BE627151A (xx)
BE627145A (xx)
BE627141A (xx)
BE507458A (xx)
BE533484A (xx)
BE547422A (xx)
BE571209A (xx)
BE582314A (xx)
BE603935A (xx)
BE641558A (xx)
BE642098A (xx)
BE642856A (xx)
BE643034A (xx)
BE643631A (xx)
BE608372A (xx)
BE644554A (xx)